Sanofi and Regeneron report positive preliminary Phase 2 program results
10 November 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
List view / Grid view
10 November 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
18 July 2011 | By Eli Lilly and Company
New study results released...
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...